For too long, “AI” has been the abbreviation for “artificial intelligence.”  Reject that label!  It’s not only limiting – it’s incorrect.  The information gathered and parsed comes from real-world sources – patients, payers, product innovators, policymakers, and providers.  It is composite data, once called “big data,” sliced and diced through machine learning and then applied to good, sometimes life-sustaining use.  It’s time we acknowledge how “AI” has become a practical source for talent and organizational enhancement.

Health Enters the Age of “Augmented Implementation”

Here’s a dive into 10 transformative examples of how “AI” enables people to tap into their significant potential to heal and accelerate care delivery.  Change is always hard, even when the advantages appear evident, as it requires revamping processes and policies.  However, as innovation theorist, AI philosopher and Nosta Lab Founder John Nosta reflects: “Culture crushes innovation.” 

Nosta shares with Medika Life readers: “AI, particularly through large language models (LLMs), is revolutionizing healthcare by fostering ‘learner-centricity.’ This approach places physicians, patients, and healthcare systems at the center of a dynamic, personalized learning process. LLMs provide tailored, context-specific knowledge, enabling real-time insights and deeper understanding. Whether it’s a clinician refining diagnostic skills or a patient comprehending treatment options, LLMs create a collaborative learning ecosystem. This synergy enhances the healthcare experience, empowering all participants through shared knowledge and continuous growth.”

The culture of medicine is storied and slow-moving. Still, these 10 approaches to weaving AI into the health system are piquing people’s priorities and enthusiasm for greater use. The wave of universal acceptance is underway.

1. Revolutionizing Patient-Clinician Interaction

Ambient Listening Technologies (ALTs) are modernizing how clinicians transcribe medical documents – by capturing, recording, managing, and analyzing audio data from the patient exam room. AI transcription tools like the Nuance Dragon Ambient eXperience (DAX) from Microsoft streamline recording tasks that once consumed chunks of a clinician’s day. AI-driven transcription systems record and summarize patient-clinician conversations, enabling providers to focus on patients rather than documentation. The plus for doctors is reduced admin time; for patients, it provides the benefit of ensuring their provider has real-time notes for follow-up care delivery.

2. AI-Enhanced Diagnostics are Challenging the Future of Illness

Technologies like DeepMind AlphaFold provide unprecedented insights into protein structure prediction, accelerating drug discovery and enhancing diagnostic tools for diseases like Alzheimer’s and certain cancers. Anyone tracking the field of AI-empowered diagnostics would do well to keep a close eye on innovation in this space.  The 2024 Chemistry Nobel Prize was awarded to John Jumper, PhD, and Demis Hassabis, PhD, at Google DeepMind in London for developing this game-changing AI tool for predicting protein structures.  The Galien Foundation Prix Galien is often called the Nobel Prize of the Life Science industry.  Viz.ai, a pioneer in AI-powered disease detection and intelligent care coordination, received the 2024 Prix Galien USA Award for its Viz HCM™ (Hypertrophic Cardiomyopathy) module.  Keep an eye on these companies and their advances.

Rob Havasy, HIMSS Senior Director of Informatics Strategy, representing one of the most influence professional communities – the leaders from health institutions and governments worldwide – offered this exclusive comment to Medika Life:

“AI has been part of many radiology workflows for years, but data from our HIMSS Market Insights surveys show one of the fastest growing applications right now is ambient AI and other AI tools to relieve some of clinicians’ documentation burden. These tools either help clinicians capture information from a visit or streamline patient-provider communications by creating discharge instructions or helping to manage overflowing inboxes.”

3. Accelerating Drug Discovery and Clinical Trials

AI is catalyzing innovation in drug development, a process that traditionally spans over a decade. Platforms like Hong Kong-headquartered Insilico Medicine and companies like Exscientia are applying machine learning to design drug molecules faster than ever. Meanwhile, decentralized trials are becoming more accessible through collaborative pathways set by organizations such as the Decentralized Trials & Research Alliance (DTRA), a central gathering point for regulators and industry leaders to shift the conversation from theoretical to operational regarding implementation.

Dr. Amir Kalali and Craig Lipset, pioneers in clinical trial innovation, champion this collaborative model that draws in biopharma-sector leaders, CROs, and FDA and EMA regulators. The DTRA Co-Chairs have long advocated that decentralized clinical trials (DCTs) supported by AI tools broaden access and reduce biases. These collaborations demonstrate how AI unlocks new efficiencies and enables more inclusive participation, particularly among underrepresented populations.

4. Predictive Analytics for Patient Safety

Predictive analytics powered by AI is transforming patient safety in hospitals. For example, Qventus predicts and mitigates perioperative complications. At the same time, companies like Stasis Labs, Current Health, and Vytrac provide real-time in-patient and at-home monitoring, sending vital sign data to nurses and doctors so they know their patient status and triage care.  Amy Abernathy, MD, PhD, has served in several high-profile roles that cut across the health ecosystem, from Principal Deputy Commissioner at the Food and Drug Administration (FDA) and is now Co-Founder of Highlander Health, a bold new organization advancing clinical research and patient care through learning labs, investments, and philanthropy, comments: “AI is transforming how we approach patient safety by intervening in a proactive measure rather than a reactive one.”

5. Addressing Mental Health Needs with AI

Mental health care is becoming more accessible with AI-driven platforms such as Woebot Health and Wysa. These companies are using AI to provide scalable, CBT-based support for conditions like anxiety and depression, often meeting the needs of underserved populations without ready access to mental health services. Another approach led by GrayMatters Health enables mental health professionals to address PTSD through neuromodulation – an FDA-approved for-use approach designed through years of data aggregation.  Noted digital health pioneer, inventor, and  Founder and Curator for NextMed Health, Daniel Kraft, MD, notes: “AI-powered mental health tools are filling the gaps in traditional care delivery, providing immediate, accessible, and empathetic support when people need it most.”

6. Driving Precision Medicine

Precision medicine, enabled by AI, is bringing targeted therapies into sharper focus. Collaborating with Roche, Foundation Medicine uses genomic profiling to guide cancer treatments. Similarly, Tempus leverages AI to connect molecular and clinical data, accelerating therapeutic breakthroughs. The combination of high tech with high science has enabled scientists with support from private equity and academic institutions worldwide to create companies at the vanguard of the discipline in the UK Golden Triangle, Southeast Asia, and the Cambridge/Boston innovation hub. LABIOTECH author Willow Shah-Neville wrote a concise report of 12 biotech unicorns rated in order of their valuations according to CB Insights. It is worth examining how these fast-moving innovators apply information technology to augment their scientific implementation.

7. Streamlining Hospital Operations

AI tools enhance hospital operations, optimize workflows, and improve patient outcomes. For instance, GE Healthcare Command Centers use predictive analytics to manage patient flow. Other companies, such as LeanTaaS, with its iQueue platform, improve operating room and infusion suite scheduling. Hyro is a much-watched hospital workflow optimizer with services that cut across administrative and clinical departments and add AI to Epic workflows, improving access to care. Edward Marx, a global healthcare consultant and former Cleveland Clinic CIO, emphasizes: “Operational AI is reshaping how hospitals function, eliminating inefficiencies and ensuring resources are used where they’re needed most.”

“Top Trends in Healthcare and Life Sciences” Microsoft video episode titled “The power of information to improve healthcare,” Gil Bashe, Chair of Global Health and Purpose at FINN Partners and Medika Life Editor-in-Chief, joins Tom Lawry, formerly National Director for Artificial Intelligence Health and Life Sciences at Microsoft and now Founder of the AI consultancy Second Century, talk about the opportunities and obstacles in health, AI, and the power of information.

8. Promoting Health Equity Through AI

Medtronic AI-enabled remote monitoring devices are helping bridge the care gap in underserved areas. Similarly, PathAI, in collaboration with Quest Diagnostics, is leveraging “machine learning to improve diagnostics in resource-limited settings, ensuring equitable access to healthcare.  Michelle Longmire, MD, a Stanford-trained dermatologist and founder and CEO of Medable, which offers the research-based biopharma industry an array of research tools with a unified platform, adds: “AI’s potential lies in its scalability, which can extend high-quality care to populations previously overlooked by traditional systems.”

9. Harnessing AI for Population Health

AI is transforming public health by integrating social determinants of health into predictive models. Companies like Epic Health Research Network and Innovaccer are helping health systems anticipate and address population health challenges more effectively. Michael Rosenblatt, MD, with his storied career as a scientist and teacher, having served as Chief Medical Officer at Merck and Flagship Pioneering and now as Co-Chair of the Galien Foundation, notes: “AI-driven insights empower health systems to deploy resources strategically, reducing disparities and improving outcomes across entire communities.”

10. Empowering Patients with Wearables and Digital Health Platforms

Wearables like the Apple Watch have popularized health tracking. Still, more specialized solutions, such as AliveCor and Biobeat are examples of advanced monitors delivering medical-grade heart data enabling patients to access, manage, and share their data and connect with their physicians. Additionally, platforms like the Belong.Life Dave AI focuses on cancer care by guiding patients with tailored recommendations, educational content, and peer support.  David E. Albert, MD, Oklahoma native, physician, inventor, and serial entrepreneur, is the founder of AliveCor and a long-time AI champion, says, “AI will play a role in reducing data into manageable and actionable information for clinical decision-making.”

Looking Forward: A Future Shaped by Collaboration

AI progress in health settings during the past five years illustrates what’s possible when technology meets the demands of patient care, equity, and innovation.  

Is “AI” still threatening and misunderstood?  Absolutely! The term “artificial intelligence” is a threatening misrepresentation of the idea that people will become secondary to machines processing vast amounts of data (largely) accurately and in a blink. However, technology is continuously called upon to automate repetitive tasks.  It does not alone transform people’s health or the fractured health ecosystem – instead, it’s the human desire to question, collaborate, and generate shared – augmented – wisdom that is core to implementation.  

“Driving measurable value at scale with AI is less about the right technology and more about the right leadership. Is there a sufficient level of AI understanding at all levels of the organization?  Is your culture change-ready or change-resistant,” reflects Tom Lawry, principal of Second Century.  Is AI part of your HR plan? In the end, AI success cannot be delegated. Leadership is the catalyst for unlocking its true potential. This requires vision, strategic alignment, and a commitment to empowering teams to innovate and execute with purpose.”

As more people dip their toes into the tech waters, comfort levels are increasing rapidly. Remember the 15-year time gap between Apple’s failed Newton and the early iPhones? Once the idea of a smartphone caught on, it became a personal must. According to a Pew Research Center Survey conducted May 19 to Sept. 5, 2023, 90% of US adults say they have a smartphone. Soon, AI will be ubiquitous in most health settings.

Say so long to artificial intelligence. Welcome to the age of Augmented Implementation!

The next five years promise even more significant advances, , a thirst to use information to accelerate decision-making, fueled by curiosity and collaborations across sectors and the drive to improve lives globally.

The post AI is Transforming Health Delivery: A Five-Year Reflection appeared first on Medika Life.

The headlines often brim with excitement—just last week, Google’s DeepMind unveiled AlphaProteo, an AI that designs proteins to bind with unprecedented precision to target molecules, marking a major leap in drug discovery. The ability to generate protein binders in a single step could reshape the way we treat diseases like cancer, autoimmune disorders, and viral infections. A remarkable feat, no doubt—but it begs the question: is technology driving us further into the paradigm of “sick care”?

The “sick care” concept frames healthcare as an industry primarily designed to react to illness rather than prevent it. It’s a system built to treat disease once it has taken root, focusing its efforts on developing drugs, interventions, and surgical techniques. And indeed, this is where we see the lion’s share of technological advancements. AI has been transformative here—accelerating drug discovery, optimizing clinical trials, and personalizing treatments. The economic incentives behind such innovations are undeniable: the pharmaceutical industry thrives on the development of new drugs and with good reason. Curing or managing diseases after diagnosis is a multi-billion-dollar enterprise.

But what of the other pole of healthcare? The space where wellness, prevention, and lifestyle medicine reside? In this sphere, the story is far less dramatic. While we see incremental advancements in fitness apps, wearable technology, and AI-driven health monitoring, they pale compared to the transformative work done in sick care. And it’s not because prevention lacks importance—it’s because prevention lacks the same financial incentives.

AlphaProteo: A Case Study in “Sick Care” Innovation

Take AlphaProteo as a prime example. This AI system could fast-track treatments for cancer, autoimmune diseases, and viral infections by designing proteins that bind more effectively to disease-associated targets. In one case, AlphaProteo achieved an 88% success rate in designing a binder for BHRF1, a protein linked to autoimmune disorders, far surpassing traditional methods’ 18% success rate. This achievement is not only a technical triumph but also an economic one. The efficiency and precision of AlphaProteo could reduce the time and cost of drug development, potentially revolutionizing the industry.

Yet, in celebrating such advances, we may be reinforcing a system that is reactive by nature. We are focusing on treating diseases after they have already begun wreaking havoc on the human body. The technological revolution, it seems, is deeply intertwined with the mechanics of treating the sick rather than preventing sickness altogether. 

The Wellness Gap: Prevention and Technology

It’s not that AI is incapable of driving innovation in prevention and wellness—it’s that the incentives aren’t aligned. Prevention, by nature, is harder to quantify, monetize, and structure within the current healthcare paradigm. While we’ve seen some success stories in the wellness space—AI-driven personalized nutrition plans, predictive algorithms that gauge disease risk, and continuous health monitoring via wearable devices—the resources and attention directed here pale in comparison to the juggernaut of drug development and treatment.

Consider this: wellness and preventive care require a shift in thinking. They demand long-term investment for outcomes that may take years, even decades, to materialize fully. In contrast, sick care offers immediate, measurable returns. A breakthrough drug can earn billions in revenue within a few short years. Prevention, by contrast, often goes unnoticed because its success lies in what doesn’t happen. A disease that never manifests because of a carefully optimized lifestyle isn’t as celebrated as one that is heroically cured after diagnosis.

Why the Balance Matters

The disparity between sick care and preventive care isn’t just an economic or technological issue—it’s philosophical. It speaks to the way we view health and medicine. For centuries, healthcare has been about intervention—about stepping in after the fact to fix what’s gone wrong. But if we continue to pour all our technological resources into this model, we run the risk of reinforcing its limitations.

AI and technology have the potential to disrupt not only how we treat diseases but how we think about health itself. Imagine a world where AI helps us prevent disease with the same rigor and intensity it applies to curing it. AI-driven systems could personalize diets and wellness plans, continuously monitor our health markers, and predict disease years before it manifests. Such an approach could shift the very foundation of healthcare—from reactive to proactive, from intervention to prevention.

Is a Preventive Revolution Possible?

The real challenge lies in the structure of healthcare economics. For a true preventive revolution to take place, the incentives must change. Governments, healthcare systems, and tech companies must begin to value and invest in wellness with the same fervor they invest in drugs and treatments. In the meantime, sick care remains the dominant paradigm, and technology, for all its brilliance, is largely reinforcing this model.

The future of healthcare could be one where AI is equally adept at helping us live healthier, longer lives as it is at curing diseases. But for that future to materialize, we need to rethink our approach to healthcare innovation. Is it enough to celebrate breakthroughs like AlphaProteo, or should we challenge ourselves to develop technologies that keep us from needing these breakthroughs in the first place? We stand at a crossroads. Will AI continue to drive us deeper into the domain of sick care, or will we harness its power to reshape healthcare as we know it—focusing not just on extending life but on enhancing the quality of life from the very start?

The post Is Technology Reinforcing the Very Essence of “Sick Care?” appeared first on Medika Life.